Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2008

Mar 4, 2008

29831_dirs_2008-03-03_08707f99-f9eb-48f0-80b0-77e1054799d3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2008-02-28

Reporting Person: SUSMAN SALLY (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-02-28 Common Stock A 16462 Acquired 16462.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-02-28 Stock Appreciation Rights $22.55 A 66607 Acquired 2013-02-28 Common Stock (66607.00) Direct

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units.

F2: The stock appreciation rights will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant